PUBLISHER: Grand View Research | PRODUCT CODE: 1170865
PUBLISHER: Grand View Research | PRODUCT CODE: 1170865
The global biopharma plastics market size is expected to reach USD 11.29 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.2% from 2022 to 2030. The growing awareness about lightweight materials used in the healthcare industry in various applications such as containers, valves, and clamps is expected to drive the demand for silicones. Superior characteristics of the biopharma plastic polymers make them highly compatible with rubber, adhesives, metals, and coatings, thus increasing their preference over other products. Increasing production of biopharma plastic products is the key factor behind the growth of this market.
The revision of the regulatory framework associated with the biopharma industry is expected to increase the safety, efficacy, and performance standards of biopharma plastic-based medical products. As a result, the demand for superior-quality biopharma plastics is expected to grow in Europe in the coming years. The market in the region is highly regulated, with stringent norms enforced for the production of biopharma plastics by the World Health Organization.
The growing demand for biopharma plastics to manufacture various medical equipment, such as drug delivery systems, beakers, test tubes, and containers for laboratory ware, IV, and dialysis fluid is expected to positively impact the growth of the market over the forecast period. The growing biopharma/medical industry coupled with the increasing demand for a hygienic and clean environment at healthcare facilities is expected to have a positive impact on the market growth over the forecast period.
The high demand for advanced healthcare services owing to the availability of well-developed healthcare infrastructure, increasing incidences of cardiovascular diseases, and rising aging population are anticipated to drive the demand for biopharma medical devices, which, in turn, is expected to drive polyethylene terephthalate demand in biopharma applications.